Maxillary nerve is the second most affected branch in trigeminal neuralgia. It is treated with medical drugs like carbamazepine and baclofen. For long-term pain relief, chemical neurolysis and radiofrequency ablation… Click to show full abstract
Maxillary nerve is the second most affected branch in trigeminal neuralgia. It is treated with medical drugs like carbamazepine and baclofen. For long-term pain relief, chemical neurolysis and radiofrequency ablation (RFA) are commonly undertaken, of which RFA results in longer duration of pain relief, shorter onset and increased safety.[1] Chemical neurolysis of maxillary nerve can also result in serious complications.[2] RFA in chronic facial pain is being increasingly used with promising results.[3] We describe two patients where percutaneous RFA of peripheral maxillary nerve was undertaken without fluoroscopic/computed tomography (CT) guidance.
               
Click one of the above tabs to view related content.